97 related articles for article (PubMed ID: 10544905)
1. The risk of fetal loss in family members of probands with factor V Leiden mutation.
Tormene D; Simioni P; Prandoni P; Luni S; Innella B; Sabbion P; Girolami A
Thromb Haemost; 1999 Oct; 82(4):1237-9. PubMed ID: 10544905
[TBL] [Abstract][Full Text] [Related]
2. Factor V Leiden mutation and the risk of venous thromboembolism in pregnant women.
Tormene D; Simioni P; Prandoni P; Luni S; Zerbinati P; Sartor D; Franz F; Girolami A
Haematologica; 2001 Dec; 86(12):1305-9. PubMed ID: 11726323
[TBL] [Abstract][Full Text] [Related]
3. Factor V Leiden mutation in relation to fecundity and miscarriage in women with venous thrombosis.
van Dunné FM; Doggen CJ; Heemskerk M; Rosendaal FR; Helmerhorst FM
Hum Reprod; 2005 Mar; 20(3):802-6. PubMed ID: 15618258
[TBL] [Abstract][Full Text] [Related]
4. Risk of pregnancy-related venous thrombosis in carriers of severe inherited thrombophilia.
Martinelli I; Legnani C; Bucciarelli P; Grandone E; De Stefano V; Mannucci PM
Thromb Haemost; 2001 Sep; 86(3):800-3. PubMed ID: 11583310
[TBL] [Abstract][Full Text] [Related]
5. Third trimester nonrecurrent fetal loss is associated with factor V Leiden and prothrombin gene mutations.
Karateke A; Haliloglu B; Gurbuz A
J Matern Fetal Neonatal Med; 2005 Nov; 18(5):299-304. PubMed ID: 16390788
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of factor V G1691A (factor V-Leiden) and prothrombin G20210A gene mutations in a recurrent miscarriage population.
Finan RR; Tamim H; Ameen G; Sharida HE; Rashid M; Almawi WY
Am J Hematol; 2002 Dec; 71(4):300-5. PubMed ID: 12447960
[TBL] [Abstract][Full Text] [Related]
7. [Genetic thrombophilic defects (Factor V Leiden, prothrombin G20210A, MTHFR C677T) in women with recurrent fetal loss].
Kovacheva K; Ivanov P; Konova E; Simeonova M; Komsa-Penkova R
Akush Ginekol (Sofiia); 2007; 46(7):10-6. PubMed ID: 18333414
[TBL] [Abstract][Full Text] [Related]
8. Fetal loss in women with hereditary thrombophilic defects and concomitance of other thrombophilic defects: a retrospective family study.
Korteweg FJ; Folkeringa N; Brouwer JL; Erwich JJ; Holm JP; van der Meer J; Veeger NJ
BJOG; 2012 Mar; 119(4):422-30. PubMed ID: 22324918
[TBL] [Abstract][Full Text] [Related]
9. The relationship of the factor V Leiden mutation and pregnancy outcomes for mother and fetus.
Dizon-Townson D; Miller C; Sibai B; Spong CY; Thom E; Wendel G; Wenstrom K; Samuels P; Cotroneo MA; Moawad A; Sorokin Y; Meis P; Miodovnik M; O'Sullivan MJ; Conway D; Wapner RJ; Gabbe SG;
Obstet Gynecol; 2005 Sep; 106(3):517-24. PubMed ID: 16135581
[TBL] [Abstract][Full Text] [Related]
10. Factor V Leiden and G20210A prothrombin mutations in patients with recurrent pregnancy loss: data from the southeast of Turkey.
Altintas A; Pasa S; Akdeniz N; Cil T; Yurt M; Ayyildiz O; Batun S; Isi H
Ann Hematol; 2007 Oct; 86(10):727-31. PubMed ID: 17572893
[TBL] [Abstract][Full Text] [Related]
11. Co-segregation of thrombophilic disorders in factor V Leiden carriers; the contributions of factor VIII, factor XI, thrombin activatable fibrinolysis inhibitor and lipoprotein(a) to the absolute risk of venous thromboembolism.
Libourel EJ; Bank I; Meinardi JR; Baljé -Volkers CP; Hamulyak K; Middeldorp S; Koopman MM; van Pampus EC; Prins MH; Büller HR; van der Meer J
Haematologica; 2002 Oct; 87(10):1068-73. PubMed ID: 12368162
[TBL] [Abstract][Full Text] [Related]
12. Maternal IVS1-401 T allele of the estrogen receptor alpha is an independent predictor of late fetal loss.
Gerhardt A; Scharf RE; Mikat-Drozdzynski B; Krüssel JS; Bender HG; Zotz RB
Fertil Steril; 2006 Aug; 86(2):448-53. PubMed ID: 16753154
[TBL] [Abstract][Full Text] [Related]
13. [Frequency of antiphospholipid antibodies and Leiden mutation of hemostasis Factor V in unexplained recurrent fetal and embryo loss].
Boianovski B; Ruseva M; Ganev V; Karag'ozova Zh; Mladenova A; Nikolov K; Baleva M; Dimitrova V; Chernev T; Ivanov S
Akush Ginekol (Sofiia); 2001; 40(3):11-4. PubMed ID: 11785358
[TBL] [Abstract][Full Text] [Related]
14. [Pregnancy-associated venous thrombosis in women with hereditary heterozygous factor V Leiden and/or factor II gene mutations].
Samama MM; Rached RA; Conard J; Horellou MH; Elalamy I
Bull Acad Natl Med; 2004; 188(8):1377-93; discussion 1393-6. PubMed ID: 15918665
[TBL] [Abstract][Full Text] [Related]
15. Risk of venous thrombosis in carriers of the prothrombin G20210A variant and factor V Leiden and their interaction with oral contraceptives.
Aznar J; Vayá A; Estellés A; Mira Y; Seguí R; Villa P; Ferrando F; Falcó C; Corella D; España F
Haematologica; 2000 Dec; 85(12):1271-6. PubMed ID: 11114134
[TBL] [Abstract][Full Text] [Related]
16. Pregnancy outcome in women with factor V Leiden and recurrent miscarriage.
Jivraj S; Makris M; Saravelos S; Li TC
BJOG; 2009 Jun; 116(7):995-8. PubMed ID: 19522801
[TBL] [Abstract][Full Text] [Related]
17. Increased risk for fetal loss in carriers of the factor V Leiden mutation.
Meinardi JR; Middeldorp S; de Kam PJ; Koopman MM; van Pampus EC; Hamulyák K; Prins MH; Büller HR; van der Meer J
Ann Intern Med; 1999 May; 130(9):736-9. PubMed ID: 10357692
[TBL] [Abstract][Full Text] [Related]
18. Association between adverse pregnancy outcomes and maternal factor V G1691A (Leiden) and prothrombin G20210A genotypes in women with a history of recurrent idiopathic miscarriages.
Mahjoub T; Mtiraoui N; Tamim H; Hizem S; Finan RR; Nsiri B; Almawi WY
Am J Hematol; 2005 Sep; 80(1):12-9. PubMed ID: 16138341
[TBL] [Abstract][Full Text] [Related]
19. Association of inherited thrombophilia with embryonic and postembryonic recurrent pregnancy loss.
Ivanov PD; Komsa-Penkova RS; Konova EI; Kovacheva KS; Simeonova MN; Popov JD
Blood Coagul Fibrinolysis; 2009 Mar; 20(2):134-40. PubMed ID: 19786941
[TBL] [Abstract][Full Text] [Related]
20. Factor V Leiden, pregnancy complications and adverse outcomes: the Hordaland Homocysteine Study.
Nurk E; Tell GS; Refsum H; Ueland PM; Vollset SE
QJM; 2006 May; 99(5):289-98. PubMed ID: 16613994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
